News
$Cyclacel Pharmaceuticals (CYCC.US)$ Cyclacel Pharmaceuticals to Receive European Patent Grant for Novel Pharmaceutical Compositions of Plogosertib; Patent Provides Exclusivity Until August 2040; Applications in Other Jurisdictions Pending
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
